-
VIVO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Meridian Bioscience (VIVO)
Company Profile
Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 22 | Sep 21 | Sep 20 | Sep 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 74.10 mm | 74.10 mm | 74.10 mm | 74.10 mm | 74.10 mm | 74.10 mm |
Cash burn (monthly) | 2.45 mm | (no burn) | 9.70 mm | (no burn) | 783.00 k | (no burn) |
Cash used (since last report) | 61.28 mm | n/a | 242.41 mm | n/a | 19.57 mm | n/a |
Cash remaining | 12.82 mm | n/a | -168.31 mm | n/a | 54.53 mm | n/a |
Runway (months of cash) | 5.2 | n/a | -17.4 | n/a | 69.6 | n/a |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 22.95 mm |
Total shares | 1.13 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Flynn James E | 1.13 mm | $22.95 mm |
Proequities | 0.00 | $0.00 |